» Articles » PMID: 2227418

HNF-3A, a Hepatocyte-enriched Transcription Factor of Novel Structure is Regulated Transcriptionally

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 1990 Aug 1
PMID 2227418
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte-specific gene expression requires the interaction of many proteins with multiple binding sites in the regulatory regions. HNF-3 is a site found to be important in the maximal hepatocyte-specific expression of several genes. We find that liver nuclear extracts contain three major binding activities for this site, which we call HNF-3A, HNF-3B, and HNF-3C. Purification from rat liver nuclear extracts of HNF-3A and HNF-3C reveals that each activity corresponds to a distinct polypeptide, as determined by SDS-PAGE. Peptide sequence derived from the most abundant species, HNF-3A, was used for synthesizing probes with which to isolate a cDNA clone of this protein. The encoded protein contains 466 amino acids (48.7 kD) and has binding properties identical to those of the purified protein. A 160-amino-acid region that does not resemble the binding domain of any known transcription factor is essential for DNA binding. The mRNA for HNF-3A is present in the rat liver but not in brain, kidney, intestine, or spleen, and the basis for this difference is cell-specific regulation of HNF-3A gene transcription.

Citing Articles

Cell type and dynamic state govern genetic regulation of gene expression in heterogeneous differentiating cultures.

Popp J, Rhodes K, Jangi R, Li M, Barr K, Tayeb K Cell Genom. 2024; 4(12):100701.

PMID: 39626676 PMC: 11701260. DOI: 10.1016/j.xgen.2024.100701.


Prediction and assessment of deleterious and disease causing nonsynonymous single nucleotide polymorphisms (nsSNPs) in human gene: An study.

Kamal M, Teeya S, Rahman M, Talukder M, Sarmin S, Wani T Heliyon. 2024; 10(12):e32791.

PMID: 38994097 PMC: 11237951. DOI: 10.1016/j.heliyon.2024.e32791.


Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis.

Liu X, Min S, Zhang Q, Liu Y, Zou Z, Wang N Future Sci OA. 2024; 10(1):FSO901.

PMID: 38827805 PMC: 11140636. DOI: 10.2144/fsoa-2023-0085.


FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.

Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.

PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.


Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis.

Gao B, Wu X, Bu L, Jiang Q, Wang L, Liu H Sci Adv. 2024; 10(6):eadk2285.

PMID: 38324694 PMC: 10849599. DOI: 10.1126/sciadv.adk2285.